Company intelligence / Profile preview
Fangsheng Pharmaceutical
- Ownership
- Private
- Development stage
- Other
Overview
Fangsheng Pharmaceutical has a broad portfolio of approved traditional Chinese medicines as well as small molecule drugs. The company has expanded internationally since at least 2016 with ambitions for FDA approval in the US. It maintains a robust R&D pipeline with multiple products under research across various therapeutic areas. Recent clinical results include approvals for herbal medicines targeting hyperostosis ("TengHuangJianGu"), acute bronchitis ("Xiaoer Jingxing Zhike Granules"), tension-type headache ("Yangxue Qufeng Zhitong Granule"), among others. Several programs are in Phase 3 trials or earlier stages targeting gynecological infections and gastrointestinal disorders.
- Therapeutic areas
- NeurologyPulmonologyGastroenterologyCardiovascularRheumatologyWomen's Health
- Modalities
- Herbal medicineSmall molecule drugGrowth factors
- Industry
- Biotech
Drug pipeline
14 assets13 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Fangsheng Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fangsheng Pharmaceutical.